Αποτελέσματα Αναζήτησης
The pocket guide is intended for day-to-day use on the scanner or reporting station and provides typical scan protocols, tips and tricks and guidance for reporting for the most common clinical applications of CMR.
The Pocket Guides give an overview of established normal ranges for CMR measurements, common acquisition methods and clinical indications for CMR. For each indication we provide typical scan protocols, tips and tricks, and a guide for reporting. These publications are endorsed by the EACVI. Cardiovascular Magnetic Resonance Pocket Guide.
Abstract. This document is an update to the 2013 publication of the Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Protocols. Concurrent with this publication, 3 additional task forces will publish documents that should be referred to in conjunction with the present document.
19 Μαρ 2024 · We aimed to develop a cardiac magnetic resonance (CMR)-derived model including mass localization, morphology, and tissue characterization to predict malignancy (with histology as gold standard), to compare its accuracy versus the diagnostic echocardiographic mass score, and to evaluate its prognostic ability. METHODS:
The typical cardiovascular effects of various classes of cancer therapy, together with suggested cardiovascular magnetic resonance (CMR) imaging protocols and key metrics provided by each sequence. “Recommended” and “aspirational” CMR imaging sequences to characterize the respective pathologies are suggested.
9 Νοε 2020 · The coordinating authors (Leiner and Pennell) assembled the list of experts at the request of the Society for Cardiovascular Magnetic Resonance (SCMR) Executive Committee, ensuring coverage of all classes of indications.
8 Ιαν 2019 · This study represents the largest reported experience evaluating cardiac masses in adults using cardiac magnetic resonance imaging and is the largest to examine the utility of contemporary cardiac magnetic resonance imaging techniques to distinguish benign versus malignant lesions.
